Bio Innovations Europe 2026
10 June @ 8:00 am – 11 June @ 8:00 pm Europe/The Hague
EuropaBio is joining Bio Innovations Europe 2026 as a Headline Partner.
Taking place on 10-11 June 2026 in The Hague, the event—formerly known as World Bio Markets—has seen exponential growth. Since its 2022 relaunch, pre-arranged meetings have surged from 160 to over 1,050 in 2025—a 550% increase. The 2026 edition is set to be the largest yet, hosting more than 400 attendees and facilitating 1,500 commercial meetings between bio-developers & producers, chemical manufacturers, consumer brands & intermediates, community enablers, investors & financiers and suppliers.
Delivering the Biotech future of Europe: EuropaBio at Bio-Innovations
EuropaBio, the industry association that champions innovative bioindustries, is proud to host a dedicated programme together with partner Bio-Innovations.
EFIB presents Europe’s key opinion leaders, bringing a clear statement to legislators at EU and national levels. 2026 brings legislation for simplification, defragmentation and acceleration of biotechnology as a vital global technology and Europe must ensure that it can compete in the global race to dominance for biotechnology and biomanufacturing.
In addition to an opening keynote, where the 2026 EFIB Statement will be launched, EuropaBio, through its EFIB platform, will also host dedicated workshops:
Executive Round Table: Senior stakeholders from across the corporate, policy and scientific community will discuss the priorities for Europe in 2026 and the ambition that must be delivered through legislative programmes that include the Bioeconomy Strategy, Biotech Act and Food and Feed Safety Omnibus, in addition to industrial policy levers including the European Competitiveness Fund, EU Inc. and STEP regulation.
SME Breakfast: The engine of innovation, the SME breakfast will bring together the entrepreneurs that translate Europe’s research excellence into products, delivering economic growth and supply chain resilience. The meeting will discuss their challenges and needs, resulting in the 2026 SME Statement for Industrial Biotechnology, published following the conference.
25% discount for EuropaBio’s network: BIEUEB